MyAverix Finance MyAverix Finance

F

GENOR BIOPHARMA DL-00002 (67N0)

GENOR BIOPHARMA DL-00002 (67N0) is listed on F. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 67N0

P/E ratio
18.00

GENOR BIOPHARMA DL-00002 (67N0) — FAQ

What is 67N0's P/E ratio?

The price-to-earnings (P/E) ratio for GENOR BIOPHARMA DL-00002 (67N0) is 18.00 (data as of 2026-05-23).

Does GENOR BIOPHARMA DL-00002 pay a dividend?

Dividend yield is not available in the current snapshot for GENOR BIOPHARMA DL-00002 (67N0). Check the MyAverix Finance app for the latest dividend data.

What exchange is 67N0 listed on?

67N0 is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play